Akari Therapeutics (AKTX) Earnings Date & Reports

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

AKTX is expected to report earnings to rise 4.51% to -138 cents per share on August 18

Akari Therapeutics AKTX Stock Earnings Reports

Q2'26

Est.

$-1.39

Q1'26

Missed

by $1.29

Q4'25

Missed

by $4.81

Q3'25

Missed

by $0.09

Q2'25

Beat

by $0.06

The last earnings report on May 14 showed earnings per share of -133 cents, missing the estimate of -3 cents. With 60.25K shares outstanding, the current market capitalization sits at 18.56M.

View a ticker or compare two or three

Compare

AKTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AKTX